• Product NameTelaprevir (VX-950)
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityTelaprevir (VX-950) is an HCV NS3-4A serine protease inhibitor with IC50 of 0.35 μM.
• Target NameHCV Protease inhibitor
• CAS No. 402957-28-2
• Calculated MW 679.85
• Formulation C36H53N7O6
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)C5=NC=CN=C5
  Pathways:Microbiology&virology; Proteases/Proteasome
  Receptor:HCV NS3-4A serine protease
  Boling pt:
  Melting pt:
  Solubility:DMSO: 136 mg/mL (200.04 mM)
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Lin K, et al. Antimicrob Agents Chemother, 2006, 50(5), 1813-1822.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting